Image Regenerative

What Image Regenerative does

Image Regenerative Clinic S.r.l. is an Italian private limited company headquartered in Milan that operates regenerative medicine clinics founded by Prof. Carlo Tremolada, a specialist in plastic reconstructive and maxillofacial surgery. The company's core asset is the Lipogems® platform, a proprietary Micro-Fragmented Adipose Tissue (MFAT) processing technology that mechanically processes harvested adipose tissue into injectable therapeutic material for orthopedic, aesthetic, and longevity indications. The technology holds FDA approval and is reimbursed by the Italian National Health Service, providing both regulatory validation and an institutional payer channel.

The company runs two clinic locations—Milan (headquarters) and St. Moritz, Switzerland (established 2010)—and operates a direct-to-consumer (B2C) model serving individual patients. Revenue is generated from medical procedures, consultations, and an eight-product portfolio spanning orthopedic, aesthetic, and longevity indications, with additional income potentially derived from licensing of the Lipogems® platform to third-party clinics. Pricing is procedure-based with tiered programs such as an "Under 21 privilege," and the patient mix is diversified across cash-pay aesthetic work and NHS-reimbursed orthopedic cases.

Image Regenerative has cultivated research collaborations with leading US academic medical centers including Harvard Medical School, Duke Health, Weill Cornell, and Mayo Clinic, lending external scientific validation to the Lipogems® platform. The business is founder-led and bootstrapped with no disclosed funding rounds, making the company's commercial scale and growth rate difficult to assess from public information.

Name

Image Regenerative

Legal name

Image Regenerative Clinic S.r.l.

Website

https://istitutoimage.it

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Image Regenerative Clinic S.r.l. is an Italian regenerative medicine operator founded by Prof. Carlo Tremolada, running clinics in Milan and St. Moritz that deliver Lipogems® micro-fragmented adipose tissue procedures to individual patients across orthopedic, aesthetic, and longevity indications.

Ownership category

akta.pro rank

Product category

Regenerative Medicine and Aesthetic Medical Services

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

akta.pro secondary industries

Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE), Body Contouring & Non-Invasive Aesthetic Recovery (e.g., Lymphatic Drainage) (HSADAKAM)

Keywords

• Regenerative medicine
• Aesthetic medicine
• Orthopedic treatments
• Longevity therapy
• Lipogems technology

Headquarters

HQ city

Milan

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Procedures and Treatments: Revenue generated from regenerative medicine procedures, aesthetic treatments, orthopedic treatments, and plastic surgery. Procedures include Lipogems treatments, aesthetic medicine, longevity programs, and advanced aesthetic therapies.
2. Consultation Services: Free and paid consultations for patients seeking evaluation for regenerative treatments, aesthetic procedures, and longevity programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Image Regenerative is a private medical clinic that delivers regenerative medicine, aesthetic surgery, and orthopedic treatments using its proprietary FDA-approved Lipogems® adipose tissue micro-fragmentation technology. The clinic offers aesthetic surgery, aesthetic medicine, longevity, advanced aesthetics, complementary therapies, and photodynamic therapy to patients at its Milan headquarters and St. Moritz, Switzerland location.

Product overview

Image Regenerative Clinic is a single-location medical clinic offering regenerative and aesthetic medicine services. The core offering centers on Lipogems®, a proprietary FDA-approved technology invented by Prof. Carlo Tremolada that processes micro-fragmented adipose tissue (MFAT) for tissue regeneration. The clinic provides a portfolio of services including aesthetic surgery, aesthetic medicine, longevity programs, advanced non-invasive aesthetics, complementary therapies, and photodynamic therapy. Services are delivered at two locations: Milan, Italy (headquarters) and St. Moritz, Switzerland. The product portfolio includes the Lipogems® technology platform, which serves both orthopedic (Lipogems Ortopedico) and aesthetic (Lipogems Beauty) applications, alongside traditional surgical and non-surgical aesthetic treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Aesthetic Surgery
• Aesthetic Medicine
• Longevity
• Advanced Aesthetics
• Complementary Therapies
• Photodynamic Therapy
• Lipogems® Technology / Device

Named customers4 records

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• Harvard Medical SchoolcoreStrategic or Co-development PartnerResearch partnership in regenerative medicine research. Harvard Medical School featured in Image Regenerative's science section, indicating collaborative research relationship in MFAT technology development.
• Duke HealthcoreStrategic or Co-development PartnerAcademic medical center partnership for regenerative medicine research and clinical validation of Lipogems technology.
• Weill Cornell MedicinecoreStrategic or Co-development PartnerAcademic medical partnership for regenerative medicine research collaboration.
• Mayo CliniccoreStrategic or Co-development PartnerLeading medical institution partnership for regenerative medicine research and clinical validation.
• Partner Surgical FacilitiesminorImplementation/ SI/ Consulting PartnerDay surgery facilities used for surgical procedures requiring different operating settings than the clinic's outpatient regime.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Buchinger Wilhelmi: Family-owned European medical-clinic group with locations in Germany and Spain focused on therapeutic fasting, integrative medicine, and longevity; comparable as a multi-generational premium medical-wellness operator with deep brand equity.
• Lanserhof: European luxury medical-wellness group operating premium clinics in Austria, Germany, and beyond; comparable as a high-end longevity and regenerative-wellness destination serving an international HNW clientele with multi-day programs.
• SHA Wellness Clinic: Spanish luxury integrative health and longevity clinic; comparable as a premium European destination combining regenerative medicine, aesthetics, and wellness programming for international high-net-worth guests.
• Clinica Privata Villalba: Part of the Italian GVM hospital group offering premium regenerative and orthopedic services; comparable as a larger Italian clinical operator offering both orthopedic and aesthetic regenerative treatments under a branded care model.
• Chenot Palace: Swiss-based luxury medical wellness brand operating flagship clinics in Weggis and other locations; competes for the same premium European longevity and aesthetic clientele with a similarly science-led brand narrative.

Direct peers

• Regenexx: US-based network of regenerative medicine clinics specializing in orthopedic applications of autologous biologics (including adipose- and bone-marrow-derived therapies). Comparable in combining proprietary regenerative protocols with a clinic-delivery model targeting joint and musculoskeletal conditions.
• Lipogems International: The manufacturer and IP owner of the Lipogems® technology that Image Regenerative uses; operates its own clinical applications and trains other clinics in MFAT procedures. Directly comparable as the upstream platform on which Image's clinical service model is built.

Emerging players

• Swiss Medica: European regenerative medicine clinic offering autologous stem cell therapies with an international patient base, similar premium positioning, and a portfolio spanning orthopedic, anti-aging, and aesthetic regenerative indications.
• Cellgenic: Regenerative medicine provider focused on autologous cellular therapies and exosome-based treatments; comparable as an emerging international player targeting the same elective orthopedic and aesthetic regenerative segments via a clinic-network model.

Regional players

• Palazzo Fiuggi: Italian luxury medical wellness property in Fiuggi combining longevity, weight management, and aesthetic programs; directly comparable as a domestic Italian premium medical-wellness destination competing for similar HNW Italian and international patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ImageRegenerative
• LinkedInlinkedin.com/company/istituto-image-regenerative-clinic
• Instagraminstagram.com/imageregenerative

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Image Regenerative